What does the evidence say about Omega-7 Skin Hydration Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Omega-7 Skin Hydration Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Additionally, palmitoleic acid supplementation significantly improved skin hydration and elasticity in middle-aged women []. [Koh Young Gue (2023); evidence level 2] - 2 Compared with baseline, skin hydration significantly increased at Week 6 in both groups, without significant differences between intervention and control groups. [Koh Young Gue (2023); evidence level 2] - However, after 12 weeks, skin hydration of the intervention group significantly increased as compared with the skin hydration of the control group on the left, right periorbital area, and average values (). [Koh Young Gue (2023); evidence level 2] - Palmitoleic acid (C16:1) is a common omega-7 (ω-7) monounsaturated fatty acid constituting approximately 7% of the visceral fatty acids produced by Alaskan pollock [] and has beneficial effects on human metabolism through promotion of cardiac growth, proliferation of pancreatic β-cells, regulation of lipogenesis and fatty acid desaturation in adipocytes, and alleviation of inflammation []. [Koh Young Gue (2023); evidence level 2] - FSG treatment resulted in faster re-epithelialization and reduced wound size at day 14 compared to FBD (50.2% vs. [Stone R (2021); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.